AstraZeneca has announced a new team-up with Qure.ai and a UK-based clinical team in a pilot trial to test the diagnostic capabilities of Qure.ai’s qXR software in identifying lung cancer from X-ray images. The trial will be held in clinics in Greater Manchester, which is noted for having some of […]
Real-World Data Study Finds Black and Hispanic Patients Receive Less Opioids During End-of-Life Care
A recently published study in the Journal of Clinical Oncology found that Black and Hispanic patients with cancer were significantly less likely to receive opioids during end-of-life care. In addition, the results, which came from nearly 320,000 Medicare patients 65 and older, also showed that Black […]
Modern Segregation in US Worsens Cancer Outcomes
In a newly published JAMA Oncology paper, researchers find that people living in US counties with higher levels of racial and socioeconomic segregation face a 20% increase in mortality rates. This effect was more pronounced in lung cancer, with mortality rates spiking by 50% in the most segregated […]
AJMC View: Balancing Cancer Treatment Innovation and Economic Burden
At The American Journal of Managed Care’s Institute for Value-Based Medicine event that took place this past October, speakers discussed the high cost of new therapeutics. A balance must be struck, according to Kevin Cohen, MD, of Optum Care, using data analytics to optimize care quality and […]
GAO Report Finds Certain Demographics Underrepresented in Cancer Drug Trials
A newly released report from the US Government Accountability Office finds that, despite years of health equity efforts, several key demographics are routinely underrepresented in clinical trials for new cancer therapeutics. This includes people with lower-incomes, rural residents, teens, older […]
Young Adult Cancer Patients May Have Higher Survival Rates with Medicaid Expansion
A newly published study in the Journal of Clinical Oncology found that a Medicaid expansion could help improve survival rates for young adults living with cancer. The study examined data from 87,300 young adults in 2020 with new cancer diagnoses, demonstrating that a lack of health insurance is a […]
Childhood Cancer Survivors on Public Insurance Face Barriers to Care
A recent study found that childhood cancer survivors face significant barriers of access to care when insured on public plans. The study followed patients who received care for cancer at a pediatric cancer center between the ages of 15-19. The risk of follow-up effects after transitioning to adult […]
Making the Most of Oncology Patient Support Programs
A variety of real-world factors play into oncology outcomes that aren’t necessarily captured or accounted for in randomized controlled trials (RCTs). Drugmakers, care providers, and other stakeholders are attempting to collect data and address these gaps in care using patient support programs […]
AstraZeneca’s Newest Push in Oncology RWE
The pharma giant AstraZeneca has expanded its presence in the chronic lymphocytic leukemia (CLL) space in recent years. Now, according to its VP and global medical franchise head of Hematology Carlos Doti, the company will help support these oncology therapeutic development efforts with a renewed […]
Aligning Cancer Therapeutic Evidence Between EMA and EU HTAs
Many of the health technology assessment agencies (HTAs) of EU member nations have evidence requirements for cancer drugs that are different than those of the European Medicines Agency (EMA). This disparity often delays patient access. In a new article in Value in Health, authors break down these […]
